Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Event, Trade Show

Join Google, Regeneron, Scientific American, PPD-Thermo Fisher, and Top-Tier VCs, Members of the Media, and Public and Private Biotechs Exploring the Big Questions in Health and Bio at the BioFuturetm Conference


Demy-Colton's BioFuturetm conference opens in just two weeks, featuring top innovators, executives and policymakers weighing in on what lies ahead in healthcare and bioscience.

The three-day event, held at the Lotte New York Palace in New York City, gets underway just as the rollout and readout of new Alzheimer's drugs is coming to fruition, obesity therapeutics are showing potential to reshape cardiovascular disease landscape, and AI is impacting drug discovery. Meanwhile, continuing progress of CAR-T and other therapies is leading to massive growth in startup investments, the consequences from the U.S. IRA healthcare legislation have begun to play out, and the public biotech markets are heating back up with new IPOs.

This year's attendees will address these topics as well as the big questions of systemic healthcare change, making the event a hub for insights, partnering, networking and dialog that will shape the future of health. Speakers from Google, Regeneron, Scientific American, PPD-Thermo Fisher, mediaX at Stanford University, Takeda Pharmaceuticals, CURE, Stifel, Northwell Health, PureTech, and JP Morgan among many others will bring new insights into the major trends shaping the future of healthcare. They join more than 100 investors, over 40 members of the media, and upwards of 80 public and private presenting companies across biotechnology and digital healthcare.

Opening day highlights include:

A Fireside chat, "Building a Patient-Centric Healthcare System with Heart and Why It Matters" featuring:

And a "Big Think" Plenary Session "Prescription for Progress: Moving from Sickcare to Wellcare" featuring:

Sara Jane Demy, Founder and CEO of Demy-Colton, said, "This year's BioFuture challenges us to rethink and re-engineer healthcare's horizons. With a rich tapestry of innovators and disruptors, our dialogue isn't just about innovation, but about how to humanize it for tomorrow."

BioFuturetm will be held live October 4-6, 2023. A virtual partnering option will also be offered from October 10-12, including access to the event's recorded content. Innovative public, private and seed companies are encouraged to submit an application to present at BioFuturetm. The Presenting Company Selection Committee seeks public and private companies developing new therapeutics as well as companies engaged in facilitating the discovery of new therapeutic technologies across biotech, digital medicine, AI, machine learning and big data.

For information on presentation or sponsorship opportunities, please contact Lila Taylor at [email protected]. For more information about BioFuturetm or to register, please visit www.biofuture.com and follow #BioFuture2023 on Twitter for the latest updates and discussions.

About Demy-Colton

Demy-Colton is a leading life sciences and digital health events organization, at the forefront of building networks between innovative life sciences companies and industry stakeholders. Its unique events facilitate networking on a global scale, including Biotech Showcasetm, BioFuturetm, Biotech CEO Summit Europetm, Biotech CEO Summit in La Jolla, and Demy-Colton Virtual Salons. These events build networking communities that transcend geographical boundaries and establish ongoing, high-value relationships among the industry's top decision-makers, investors and thought leaders, where investment, learning, and thoughtful conversations thrive. For more information, visit demy-colton.com.


These press releases may also interest you

at 05:38
The 26th Bakery China, co-organized by the China Association of Bakery and Confectionery Industry (CABCI) and Bakery China Exhibitions Co., Ltd., is set to take place from May 21st to 24th, 2024, at the National Exhibition and Convention Center...

at 05:35
NICE today announced results for the first quarter ended March 31, 2024, as compared to the corresponding period of the previous year. First Quarter 2024 Financial Highlights GAAP Non-GAAP Total revenue was $659.3 million and...

at 05:35
Explorance is unveiling today the full program for Explorance World 2024, marking a significant milestone as the first-ever Explorance World event and the premier gathering of its kind in Montreal, where Explorance headquarters are located. From June...

at 05:30
Spanios, a firm that created and leverages its unique 3D tumoroid platforms to validate solid tumor therapies today announced a partnership with Accelerated Biosciences, a company that licenses its commercial-grade human trophoblast stem cell (hTSC)...

at 05:00
Proofpoint, Inc., a leading cybersecurity and compliance company, today announced its Proofpoint Archive solution has achieved compliance with the Payment Card Industry Data Security Standard (PCI DSS). With this attestation, Proofpoint Archive...

at 05:00
Procede Software, a leading heavy-duty commercial vehicle dealer management system and solutions provider, announced the opening of registration for the 2024 Procede Software Conference (PSC), slated for September 16th...



News published on and distributed by: